tirzepatide and kidneys Kidney Outcomes in SURPASS: Exploring Tirzepatide's Broader Impact Effects of tirzepatide versus insulin

However, some peptide researchers explore combining GLP-1 agonists with non-overlapping peptides that target different pathways

Consistent follow-up also allows providers to monitor progress, discuss side effects, and make adjustments when clinically appropriate

However, hypoglycemia has been reported in up to 9% of overdose cases, even in the absence of insulin or sulfonylurea co-administration, particularly in non-diabetic or lean individuals

While the medication itself does not require tapering from a pharmacological standpoint, the clinical context surrounding discontinuationparticularly the management of underlying conditions like diabetes or obesitydemands careful planning and medical supervision to ensure patient safety and optimize long-term health outcomes